Danaher: A Leading Non-Tech Stock with Promising Outlook
Money

Danaher: A Leading Non-Tech Stock with Promising Outlook

authorBy Natalie Pace
DateJun 28, 2026
Read Time2 min
This article explores Danaher Corporation's (DHR) position as a leading non-technology stock, examining recent developments, analyst perspectives, and the company's diverse operational segments.

Unlocking Value: Danaher's Path Beyond Technology

Masimo's Breakthrough in Patient Monitoring Solutions

Danaher Corporation's subsidiary, Masimo, a prominent innovator in pulse oximetry and patient monitoring technologies, recently achieved a significant milestone. On June 22, the FDA granted 510(k) clearance for an advanced feature integrated into its Radius VSM® wearable continuous patient monitor. This new capability is designed to detect opioid-induced respiratory depression. Leveraging Masimo's cutting-edge smartSET™ pulse oximetry sensor platform, this feature uses sophisticated pattern recognition to analyze continuous physiological data, enabling healthcare professionals to identify early indicators of respiratory compromise in patients undergoing opioid therapy within hospital settings.

Analyst Perspectives and Market Positioning

In a distinct market event, Wolfe Research adjusted its rating for Danaher Corporation (NYSE:DHR) on June 1, downgrading it from Outperform to Peer Perform. This re-evaluation came without an assigned price target, as the firm took over coverage of the stock. Wolfe Research noted that Danaher's growth trajectory, both historically and prospectively, appears consistent with its peers. Furthermore, they pointed out that Thermo Fisher presents a more attractive valuation based on its price-to-earnings (P/E) ratio. The firm also expressed some uncertainty regarding Danaher's strategic identity following the Masimo transaction.

Danaher's Diverse Business Segments

Danaher Corporation (NYSE:DHR) is actively involved in the design, manufacturing, and distribution of a wide array of professional, medical, industrial, and commercial products and services, firmly establishing its presence as a key player in the diagnostics sector. The company's operations are strategically divided into several core segments: Diagnostics, Biotechnology, Life Sciences, and Environmental and Applied Solutions, showcasing its broad reach and diversified portfolio within the healthcare and industrial markets.

More Articles
Money
SoFi's AI-Powered Innovation Poised to Boost Growth
SoFi Technologies has introduced SoFi Coach, an AI-driven chat feature designed to provide personalized financial insights. Despite recent stock fluctuations, the company's commitment to product innovation, particularly in AI, is expected to enhance customer experience, foster cross-selling opportunities, and significantly contribute to its already rapid growth trajectory, which saw a 35% increase in customers and 41% rise in adjusted net revenue year-over-year.
By Ramit SethiJun 28, 2026
Money
AMD's MEXT Acquisition: Impact on Memory Market and Competitors
Advanced Micro Devices recently acquired MEXT, a startup specializing in AI-driven software that optimizes NAND flash to function like DRAM. This move aims to significantly reduce memory costs and expand usable memory capacity for AI workloads. While some investors might worry about its implications for companies like Micron and Sandisk, the acquisition's primary focus is on enhancing efficiency for enterprise AI, rather than replacing high-bandwidth memory crucial for large AI models. This strategic acquisition is unlikely to threaten, and may even benefit, memory manufacturers.
By Bola SokunbiJun 28, 2026
Money
Top Economist Warns Against Fed Rate Hikes for 2026
EY-Parthenon's chief economist, Greg Daco, challenges conventional wisdom regarding Federal Reserve interest rate hikes. He argues that current inflationary pressures are supply-driven, not demand-driven, and that further rate increases could harm an already fragile economy. Daco believes the Fed should maintain current rates, as higher energy prices, AI's strain on resources, and stagnant real incomes indicate a supply problem that monetary policy cannot easily resolve.
By T. Harv EkerJun 28, 2026
Money
Newmont Corporation Reports on Post-Seismic Event Operations and Financial Adjustments
Newmont Corporation (NEM) provided an update following a seismic event near its Cadia operations in New South Wales. The company confirmed that all underground personnel were safely evacuated without injuries or infrastructure damage. Operations resumed after comprehensive inspections. Concurrently, CIBC adjusted its price target for NEM to $175 from $176 while maintaining an Outperformer rating, reflecting stronger-than-expected Q1 results and updated cost expectations. Newmont primarily focuses on gold properties across various global regions.
By T. Harv EkerJun 28, 2026
Money
Micron Technology's Performance and Market Outlook
Micron Technology, Inc. (MU) is drawing significant attention as its earnings report approaches, with analysts predicting substantial growth in profit and revenue. The semiconductor giant has seen a remarkable surge in stock value over the past year. However, concerns about market volatility and stretched valuations persist among investors, prompting a cautious outlook despite strong AI-driven spending. This article explores Micron's market position and the broader semiconductor landscape.
By JL CollinsJun 28, 2026